ABC transporters are remarkably versatile machines that move a wide array of substances, including both hydrophilic and hydrophobic molecules across membranes (1) (2) (3) (4) . They are constructed with a modular design; each transporter has two nucleotidebinding domains (NBDs) and two membrane-spanning domains (often comprising six transmembrane helices). The NBDs are highly conserved modules that interact with ATP to control transport. The membrane-spanning domains show little sequence conservation, consistent with highly divergent functions within the ABC transporter family. In some cases, additional modules (solute-binding and/or regulatory domains) participate in the ABC transporter complex to regulate function. The design and adaptability of ABC transporters have apparently served life well throughout evolution, because they form one of the largest families of proteins in eubacteria, archaea and eukarya. Not surprisingly, loss of ABC transporter function is implicated in many diseases, and they are therefore important targets for therapeutics (5 ⋅ADP + P i ) and they spend the energy of ATP hydrolysis to move substances across a membrane against a gradient (6) (7) (8) . However, the mechanisms coupling enzymatic activity to substrate transfer remain controversial, and the stoichiometry of transport -the relationship between the number of ATP molecules hydrolyzed and the number of substrate molecules transported -remains uncertain (1) .
Uncertainty about the stoichiometry of transport is highlighted in the ABC transporter CFTR. CFTR forms a channel in which anions flow passively, moving across membranes down an electro-chemical gradient.
Thus, there is no fixed stoichiometry between ion movement and ATP utilization. Once the regulatory (R) domain has been phosphorylated, ATP interacts with the NBDs to gate the channel (for reviews see (9) (10) (11) .
Earlier work showed that both NBD1 and NBD2 bind 2 ATP and that NBD1 has little if any enzymatic activity whereas NBD2 can function as an ATPase. When ATP is the only nucleotide present, normal activity requires ATP hydrolysis. This has long seemed puzzling, because ATP hydrolysis does not fuel ion movement, and the number of ions flowing through the channel bears no fixed stoichiometric relationship to ATP hydrolysis. Moreover, no other ion channel is known to require the large energy of ATP hydrolysis (∆ r G'° ~ -32 kJ/mole).
Recent data show that CFTR can function as an adenylate kinase (Mg
⋅ADP + ADP), a readily reversible reaction that releases no free energy under physiologic conditions (12) (13) (14) . This finding begins to resolve the apparent puzzle of whether an ion channel requires a large energy input. This discovery may also give us clues about the transport energetics of other ABC transporters. Here we briefly review recent findings of CFTR adenylate kinase activity, and we discuss the implications for other ABC transporters.
CFTR-NBD2 has ATPase and adenylate kinase activity.
When ATP is the only nucleotide present, a recombinant CFTR NBD2 polypeptide functioned as an ATPase (Fig. 1A, B) . However, when AMP was added with ATP, it functioned as an adenylate kinase (15) . The reaction was reversible; with ADP applied alone, the NBD2 generated ATP (Fig. 1C) (16) . Moreover, both AMP and ADP suppressed the ATPase activity (15) . Ap5A, which specifically inhibits adenylate kinases by binding simultaneously to the ATP and AMP binding-sites (17, 18) , inhibited both enzymatic activities (Fig. 1D ) (15) . These and additional data established that an isolated NBD2 could function either as an ATPase or as an adenylate kinase. The two enzymatic activities shared an ATP binding-site, and there was an additional AMP binding-site (15, 16, 19) . Figure 1E shows a model. When we disrupted the ATP binding-site by mutating the conserved Walker A Lys or the conserved Walker B Asp that coordinates Mg 2+ , we abolished both enzymatic activities. In contrast, a mutation that probably lies outside the ATPsite (N1303K) (20, 21) eliminated adenylate kinase activity, but had minimal effects on ATPase activity (16) . Thus, NBD2 harbored distinct ATP and AMP binding-sites.
CFTR has intrinsic adenylate kinase activity in NBD2 that gates the channel. While earlier work demonstrated that the NBD2 enzymatic activity required for normal channel gating could be an ATPase, more recent data indicate that it also can be an adenylate kinase (16) .
First, when ATP is the only nucleotide present, the relationship between ATP concentration and current (or channel opening rate) shows simple MichaelisMenten behavior with a Hill coefficient of 1 ( Fig. 2A) (16, 20, 22, 23) .
These results suggest that interaction of a single ATP molecule (or interactions of ATP with equivalent sites) opens the channel. Adding AMP alone evoked no current on its own. But when added with ATP, AMP switched the relationship between ATP concentration and current to one with positive two-site cooperativity for ATP with a Hill coefficient of 1.6 ( Fig. 2A) . These data indicate that at least two ATP molecules interact with CFTR and that interaction of one ATP enhances interaction of the other. Thus, AMP induced a different gating mechanism.
Second, transfer of a phosphate between ATP and AMP (the adenylate kinase reaction) was required for normal current generation and positive cooperativity. Supporting this conclusion, AMP-NH2, which cannot serve as a phosphate acceptor, interacted with the AMP-site (16) but inhibited current non-competitively with ATP and did not induce positive cooperativity.
Third, a specific inhibitor of adenylate kinases, Ap 5 A, reduced the rate of channel opening and induced a pattern of negative cooperativity for ATP. The data indicated that Ap 5 A inhibited CFTR by simultaneously interacting with two sites, an ATP binding-site and an AMP binding-site (Fig. 1E, 2A ).
Fourth, mutating the ATP binding-site in NBD2 disrupted both ATPase-dependent and adenylate kinase-dependent gating. In contrast, mutating Asn1303 (which appears to lie outside the ATP-site based on the structure of other NBDs (21)) to Lys (N1303K) abolished the adenylate kinasedependent gating without reducing the potency of ATP in ATPase-dependent gating. Thus, N1303K selectively interfered with adenylate kinase activity, just as it did in a recombinant NBD2.
Fifth, ADP inhibits current (24) (25) (26) . But in behavior that is very unusual for an inhibitor, it also generated a Hill coefficient for ATP of >1 (Fig. 2B) . This result suggests cooperativity with interaction of one ATP enhancing the interaction of a second ATP. These data are consistent with AMP formation from ADP via phosphotransfer.
Sixth, in a recombinant CFTR NBD2 (Fig.  1C) , two ADP molecules interacted cooperatively. Moreover in CFTR, current inhibition showed positive cooperativity for ADP (27) . These and other data suggest that the reverse adenylate kinase reaction contributes to ADP-dependent inhibition.
These results indicate that NBD2 harbors intrinsic adenylate kinase activity that gates CFTR. Because this enzymatic reaction releases little if any energy under physiologic conditions, these findings bring the energetics of CFTR ion transfer and gating in line with that of other ion channels, none of which are known to require the energy of ATP hydrolysis for gating. They also demonstrate a previously unrecognized enzymatic activity for an ABC transporter.
Does ATPase or adenylate kinase activity gate CFTR in vivo?
Is adenylate kinase activity only a laboratory phenomenon, or does it actually occur in cells? Cellular ATP concentrations lie well above the K m for both reactions (Table 1) , so ATP concentrations will not determine which enzymatic activity occurs in cells. Importantly, intracellular AMP concentrations range from 10 to 700 µM (28-32) and the AMP K m value of CFTR is ~70 µM (16) . With these values, cellular AMP would switch CFTR enzymatic activity from ATPase to adenylate kinase. Therefore, we conclude that CFTR will function predominantly as an adenylate kinase in vivo. This conclusion is further supported by the fact that other adenylate kinases have AMP K m values similar to CFTR (33, 34) . We therefore expect that like them, the CFTR adenylate kinase function will be active under physiologic conditions.
Implications for structure.
How is it that one protein is capable of functioning either as an ATPase or as an adenylate kinase? The crystal structures of ABC transporter NBDs (4) and adenylate kinases (14, 35) provide some clues. ATPases possess an ATP binding-site and adenylate kinases contain an ATP bindingsite plus an AMP binding-site. Importantly, the core ATP-binding region containing a Walker A motif is very similar for both protein families (36, 37) . This structure most likely comprises the ATP-site that we found was common to the ATPase and adenylate kinase activities of CFTR.
Where is the AMP binding-site?
In adenylate kinases, the AMP-site can display considerable structural diversity (38) and can show little sequence conservation between kingdoms (39, 40) . In CFTR, the AMP-site is unknown, but we speculate that it may lie near the NBD1:NBD2 dimer interface. Positioning the AMP-site there would place it near the ATP-site where it is available for phosphotransfer.
Implications for NBD dimerization.
Biochemical and structural evidence suggest that the NBDs of ABC transporters can form dimers (Fig. 3) (21,41-44 ). In the dimer structure, the NBDs sit in a head-to-tail configuration forming two ATP bindingsites at their interface.
Both NBDs contribute to each ATP binding-site, with the Walker A motif of one NBD and the "Signature" LSGGQ motif of the other NBD sandwiching an ATP between them. Interestingly, dimerization is a mechanism that generates positive cooperativity. Thus, finding that AMP altered CFTR gating so that two ATP molecules cooperated in opening CFTR suggests that adenylate kinase activity induces ATP-dependent NBD1:NBD2 dimerization.
These data indicate that NBD dimerization in an ABC transporter has a functional consequence; in the case of CFTR that consequence is channel opening.
These observations and speculations raise additional questions. a) If dimerization is key for channel opening and ATP applied alone opens the channel, then why don't we see ATP-dependent positive cooperativity in the absence of AMP? When ATP is the only nucleotide present, it produces similar gating, and it generates the same net activity as when AMP is also present. Thus, although we expect dimerization to occur with ATP alone, there is no correlate for it in the ATP dose-response curve (16, 20, 22, 23) . Perhaps relatively stable ATP binding (and the lack of enzymatic activity) at the NBD1 Walker A: NBD2 "Signature" interface leads to opening when ATP binds to the NBD2 Walker A : NBD1 "LSGGQ" site (45) (46) (47) . This scenario could account for the lack of observable cooperativity as evidenced by the Hill coefficient of 1 ( Fig.  2A) 
Do other ABC transporters function as adenylate kinases?
The apparent disconnect between a protein that forms a passive pore and yet utilizes the high-energy ATPase activity drove the discovery of endogenous adenylate kinase activity in CFTR. The power of the patchclamp technique for studying single CFTR molecules facilitated that work. We now wonder if other ABC transporters also function as adenylate kinases. Certainly for ABC transporters that actively pump substrate against electrochemical gradients, energy from an ATPase will be required, and adenylate kinase activity would not be expected.
However, it is not likely that all other ABC transporters actively pump substrate. And in fact, in many cases it has been difficult to determine whether or not an ABC transporter performs work (51) . For example, some ABC transporters move hydrophobic substrates; because such substrates associate with membranes, it has been difficult to learn if transport occurs against a concentration gradient.
In addition, following their translocation, some substrates are rapidly modified so that the concentration of unmodified substrate remains low on the side of the membrane where they are released. As a result, it is unknown whether substrate movement occurs uphill against an electrochemical gradient or downhill. Finally, some ABC transporters, such as the sulphonylurea receptor (SUR) (52), are not known to perform any transmembrane transport; instead, they regulate other processes.
If substrate flow is energetically neutral or downhill, then adenylate kinase activity could suffice to control transport. When the ABC multidrug transporter LmrA of Lactococcus lactis was studied in the presence of ADP, downhill substrate transport and ATP formation were demonstrated (53). It would be interesting to determine whether ATP was synthesized from ADP and P i or from two ADP molecules via adenylate kinase activity. We also speculate that the adenylate kinase reaction could provide a way to couple transport to the cellular metabolic state. For example, SUR1 is an ABC transporter that senses cellular metabolic state and controls inwardly rectifying K + channels (Kir6.2) (54). High ATP concentrations close the SUR1:Kir6. 2 complex, depolarizing pancreatic β cells so they secrete insulin. When ATP concentrations fall or in the presence of ADP or ATP plus AMP, channels open, thereby suppressing insulin secretion (55, 56) . Adenylate kinase activity could regulate this process if a cytosolic adenylate kinase associated with the SUR:Kir complex or if an NBD had intrinsic adenylate kinase activity. We speculate that adenylate kinase activity intrinsic to other ABC transporters might provide a physiologic mechanism to couple function with a cell's metabolic state by sensing the relative amounts of ATP, ADP and AMP.
The existence of two different but related enzymatic activities in other ABC transporters may help explain the current uncertainty about how enzymatic activity couples to substrate transfer, as well as the difficulty in establishing the relationship between the number of ATP molecules utilized and the number of substrate molecules transported (1, 51 
